nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.146	0.297	CbGpPWpGaD
Ethosuximide—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.111	0.225	CbGpPWpGaD
Ethosuximide—Myopia—Varenicline—nicotine dependence	0.0722	0.143	CcSEcCtD
Ethosuximide—CYP3A43—Xenobiotics—CYP2A7—nicotine dependence	0.0376	0.0762	CbGpPWpGaD
Ethosuximide—Libido increased—Varenicline—nicotine dependence	0.0259	0.0511	CcSEcCtD
Ethosuximide—Upset stomach—Varenicline—nicotine dependence	0.0241	0.0475	CcSEcCtD
Ethosuximide—Paranoia—Varenicline—nicotine dependence	0.0231	0.0456	CcSEcCtD
Ethosuximide—Suicidal ideation—Varenicline—nicotine dependence	0.0225	0.0444	CcSEcCtD
Ethosuximide—Disturbance in attention—Varenicline—nicotine dependence	0.0182	0.0359	CcSEcCtD
Ethosuximide—Aggression—Varenicline—nicotine dependence	0.0179	0.0354	CcSEcCtD
Ethosuximide—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0177	0.0359	CbGpPWpGaD
Ethosuximide—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0156	0.0316	CbGpPWpGaD
Ethosuximide—CYP3A43—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0154	0.0312	CbGpPWpGaD
Ethosuximide—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0151	0.0307	CbGpPWpGaD
Ethosuximide—Mental disability—Varenicline—nicotine dependence	0.0137	0.027	CcSEcCtD
Ethosuximide—Euphoric mood—Varenicline—nicotine dependence	0.0135	0.0267	CcSEcCtD
Ethosuximide—Sleep disorder—Varenicline—nicotine dependence	0.0132	0.0261	CcSEcCtD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0126	0.0256	CbGpPWpGaD
Ethosuximide—Lethargy—Varenicline—nicotine dependence	0.0117	0.023	CcSEcCtD
Ethosuximide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0114	0.0224	CcSEcCtD
Ethosuximide—Psychotic disorder—Varenicline—nicotine dependence	0.0112	0.0221	CcSEcCtD
Ethosuximide—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.011	0.0222	CbGpPWpGaD
Ethosuximide—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0109	0.0222	CbGpPWpGaD
Ethosuximide—Irritability—Varenicline—nicotine dependence	0.0109	0.0216	CcSEcCtD
Ethosuximide—Abdominal pain upper—Varenicline—nicotine dependence	0.0105	0.0206	CcSEcCtD
Ethosuximide—Breast disorder—Varenicline—nicotine dependence	0.0103	0.0204	CcSEcCtD
Ethosuximide—Cramp muscle—Varenicline—nicotine dependence	0.0103	0.0203	CcSEcCtD
Ethosuximide—Abdominal discomfort—Varenicline—nicotine dependence	0.00948	0.0187	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00874	0.0173	CcSEcCtD
Ethosuximide—Urinary tract disorder—Varenicline—nicotine dependence	0.00782	0.0154	CcSEcCtD
Ethosuximide—Connective tissue disorder—Varenicline—nicotine dependence	0.00778	0.0154	CcSEcCtD
Ethosuximide—Urethral disorder—Varenicline—nicotine dependence	0.00776	0.0153	CcSEcCtD
Ethosuximide—Erythema multiforme—Varenicline—nicotine dependence	0.00749	0.0148	CcSEcCtD
Ethosuximide—Eye disorder—Varenicline—nicotine dependence	0.0074	0.0146	CcSEcCtD
Ethosuximide—Immune system disorder—Varenicline—nicotine dependence	0.00715	0.0141	CcSEcCtD
Ethosuximide—Mediastinal disorder—Varenicline—nicotine dependence	0.00713	0.0141	CcSEcCtD
Ethosuximide—CYP3A43—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00713	0.0144	CbGpPWpGaD
Ethosuximide—Mental disorder—Varenicline—nicotine dependence	0.00694	0.0137	CcSEcCtD
Ethosuximide—Malnutrition—Varenicline—nicotine dependence	0.00689	0.0136	CcSEcCtD
Ethosuximide—CYP3A43—Biological oxidations—CYP2A7—nicotine dependence	0.00672	0.0136	CbGpPWpGaD
Ethosuximide—CYP3A43—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00663	0.0134	CbGpPWpGaD
Ethosuximide—Muscle spasms—Varenicline—nicotine dependence	0.00663	0.0131	CcSEcCtD
Ethosuximide—Agitation—Varenicline—nicotine dependence	0.00633	0.0125	CcSEcCtD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00628	0.0127	CbGpPWpGaD
Ethosuximide—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0062	0.0126	CbGpPWpGaD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00583	0.0115	CcSEcCtD
Ethosuximide—Nervous system disorder—Varenicline—nicotine dependence	0.00552	0.0109	CcSEcCtD
Ethosuximide—Skin disorder—Varenicline—nicotine dependence	0.00546	0.0108	CcSEcCtD
Ethosuximide—Anorexia—Varenicline—nicotine dependence	0.00536	0.0106	CcSEcCtD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00509	0.0103	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00509	0.0103	CbGpPWpGaD
Ethosuximide—Somnolence—Varenicline—nicotine dependence	0.005	0.00987	CcSEcCtD
Ethosuximide—Decreased appetite—Varenicline—nicotine dependence	0.00489	0.00965	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00486	0.00958	CcSEcCtD
Ethosuximide—Fatigue—Varenicline—nicotine dependence	0.00485	0.00957	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Varenicline—nicotine dependence	0.0046	0.00908	CcSEcCtD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00455	0.00923	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00454	0.00921	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00449	0.00911	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00448	0.00909	CbGpPWpGaD
Ethosuximide—Urticaria—Varenicline—nicotine dependence	0.00447	0.00882	CcSEcCtD
Ethosuximide—Abdominal pain—Varenicline—nicotine dependence	0.00445	0.00878	CcSEcCtD
Ethosuximide—Hypersensitivity—Varenicline—nicotine dependence	0.00414	0.00818	CcSEcCtD
Ethosuximide—Asthenia—Varenicline—nicotine dependence	0.00404	0.00796	CcSEcCtD
Ethosuximide—Diarrhoea—Varenicline—nicotine dependence	0.00385	0.00759	CcSEcCtD
Ethosuximide—Dizziness—Varenicline—nicotine dependence	0.00372	0.00734	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00369	0.00748	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00368	0.00747	CbGpPWpGaD
Ethosuximide—Vomiting—Varenicline—nicotine dependence	0.00358	0.00706	CcSEcCtD
Ethosuximide—Rash—Varenicline—nicotine dependence	0.00355	0.007	CcSEcCtD
Ethosuximide—Dermatitis—Varenicline—nicotine dependence	0.00354	0.00699	CcSEcCtD
Ethosuximide—Headache—Varenicline—nicotine dependence	0.00352	0.00695	CcSEcCtD
Ethosuximide—Nausea—Varenicline—nicotine dependence	0.00334	0.00659	CcSEcCtD
Ethosuximide—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00287	0.00582	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00271	0.00549	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00267	0.00541	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00211	0.00428	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00208	0.00423	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00208	0.00422	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00208	0.00421	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00196	0.00397	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00196	0.00397	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00193	0.00392	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00193	0.00391	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00171	0.00347	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2A7—nicotine dependence	0.00115	0.00233	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000965	0.00196	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000909	0.00184	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000897	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000463	0.000938	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000335	0.00068	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000335	0.000678	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000156	0.000315	CbGpPWpGaD
